Vaccines: past, present and future

被引:350
作者
Plotkin, SA [1 ]
机构
[1] Univ Penn, Doylestown, PA 18901 USA
关键词
D O I
10.1038/nm1209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The vaccines developed over the first two hundred years since Jenner's lifetime have accomplished striking reductions of infection and disease wherever applied. Pasteur's early approaches to vaccine development, attenuation and inactivation, are even now the two poles of vaccine technology. Today, purification of microbial elements, genetic engineering and improved knowledge of immune protection allow direct creation of attenuated mutants, expression of vaccine proteins in live vectors, purification and even synthesis of microbial antigens, and induction of a variety of immune responses through manipulation of DNA, RNA, proteins and polysaccharides. Both noninfectious and infectious diseases are now within the realm of vaccinology. The profusion of new vaccines enables new populations to be targeted for vaccination, and requires the development of routes of administration additional to injection. With all this come new problems in the production, regulation and distribution of vaccines.
引用
收藏
页码:S5 / S11
页数:7
相关论文
共 87 条
[41]   Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination [J].
Markowitz, M ;
Jin, X ;
Hurley, A ;
Simon, V ;
Ramratnam, B ;
Louie, M ;
Deschenes, GR ;
Ramanathan, M ;
Barsoum, S ;
Vanderhoeven, J ;
He, T ;
Chung, C ;
Murray, J ;
Perelson, AS ;
Zhang, LQ ;
Ho, DD .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (05) :634-643
[42]   Macroflux® microprojection array patch technology:: A new and efficient approach for intracutaneous immunization [J].
Matriano, JA ;
Cormier, M ;
Johnson, J ;
Young, WA ;
Buttery, M ;
Nyam, K ;
Daddona, PE .
PHARMACEUTICAL RESEARCH, 2002, 19 (01) :63-70
[43]   Needle-free skin patch vaccination method for anthrax [J].
Matyas, GR ;
Friedlander, AM ;
Glenn, GM ;
Little, S ;
Yu, JM ;
Alving, CR .
INFECTION AND IMMUNITY, 2004, 72 (02) :1181-1183
[44]   HUMAN HEPATITIS-B VACCINE FROM RECOMBINANT YEAST [J].
MCALEER, WJ ;
BUYNAK, EB ;
MAIGETTER, RZ ;
WAMPLER, DE ;
MILLER, WJ ;
HILLEMAN, MR .
NATURE, 1984, 307 (5947) :178-180
[45]   Modified vaccinia ankara: Potential as an alternative smallpox vaccine [J].
McCurdy, LH ;
Larkin, BD ;
Martin, JE ;
Graham, BS .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1749-1753
[46]   Life-style vaccines [J].
Mettens, P ;
Monteyne, P .
BRITISH MEDICAL BULLETIN, 2002, 62 :175-186
[47]   Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery [J].
Mikszta, JA ;
Alarcon, JB ;
Brittingham, JM ;
Sutter, DE ;
Pettis, RJ ;
Harvey, NG .
NATURE MEDICINE, 2002, 8 (04) :415-419
[48]   Towards the rational design of Th1 adjuvants [J].
Moingeon, P ;
Haensler, J ;
Lindberg, A .
VACCINE, 2001, 19 (31) :4363-4372
[49]   Cancer vaccines [J].
Moingeon, P .
VACCINE, 2001, 19 (11-12) :1305-1326
[50]   Progress in DNA-based heterologous prime-boost immunization strategies for malaria [J].
Moore, AC ;
Hill, AVS .
IMMUNOLOGICAL REVIEWS, 2004, 199 (01) :126-143